The kidney transplant market is a crucial component of the healthcare industry. Kidney transplantation involves surgically placing a healthy kidney from a living or deceased donor into a patient whose kidneys have failed. It is primarily used as a treatment for end-stage kidney failure or kidney failure. Kidney transplantation is usually an option when dialysis can no longer sufficiently support a patient's health.
The global kidney transplant market is estimated to be valued at US$ 99232.33 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period from 2024 to 20301.
Kidney transplantation procedures involve harvesting a healthy kidney from a deceased or living donor and implanting it into a patient whose kidneys have failed. These procedures help improve the quality of life for patients with end-stage renal disease who are otherwise dependent on regular dialysis treatments. Advancements in surgical techniques, immunosuppressive drugs, and organ preservation methods have made kidney transplantation a viable treatment option.
Key Takeaways
Key players operating in the kidney transplant market are Alumasc Group Plc, Binderholz GmbH, Bauder Ltd, Forbo International SA, Certain Teed Corporation, The Turner Corp, Clark Group, Gilbane Building Co, Hensel Phelps, and The Whiting-Turner Contracting Co.
The rising incidence of chronic kidney diseases (CKD) due to diabetes, hypertension, vascular diseases, and glomerulonephritis is expected to offer lucrative growth opportunities for players in the Kidney Transplant Market Demand According to data by the National Kidney Foundation, over 90,000 Americans are currently on the kidney transplant waiting list with more being added daily due to the shortage of organ donors.
The increasing efforts made by regional governments and transplant centers to spread awareness about organ donation among citizens and modern transplant technologies adoption are driving the international expansion of major kidney transplant market players. Some key markets like US, China, and European countries are focusing on self-sufficiency in organ transplantation through deceased and living donor programs.
Market Drivers
The rising prevalence of end-stage renal disease (ESRD) due to diabetes, hypertension, and other chronic conditions has been a key driver of the kidney transplant market growth. In many developed nations, ESRD cases have grown to become a major health burden. For example, the Centers for Disease Control and Prevention (CDC) estimates that over 750,000 Americans currently have ESRD.
Market Restraints
Lack of organ donors remains one of the major challenges faced by the kidney transplant market. Unlike liver and heart transplants, kidney transplantation relies solely on living or deceased organ donors. Long donor organ shortage lists and waiting times of 3 to 5 years for suitable kidneys limits timely access to this life-saving treatment option. Many patients succumb to kidney failure while awaiting transplantation. Cultural and ethical barriers in some countries to organ donation further compound the issue.
Segment Analysis
Kidney transplantation is one of the key segments in the Kidney Transplant Market. Kidney transplantation from living donors dominates this segment currently, accounting for over 60% of the total kidney transplants performed globally. This is primarily due to better outcomes and increased organ availability compared to deceased donor kidney transplantation. However, demand for deceased donor kidney transplantation is growing at a faster rate due to rise in organ failure cases and lack of living donors.
Global Analysis
North America region currently dominates the global Kidney Transplant Market accounting for over 40% of the total market share. This is due to presence of excellent healthcare infrastructure and high adoption of advanced transplant procedures in countries like US and Canada. Asia Pacific is projected to be the fastest growing market during the forecast period owing to large patient pool, increasing awareness about organ donation and transplantation, and rising healthcare spending in countries like China and India.
Get more insights, On Kidney Transplant Market
Comments
0 comment